Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (6)
  • 2025 (44)
  • 2024 (32)
  • 2023 (22)
  • 2022 (32)
  • 2021 (57)
  • 2020 (48)
  • 2019 (46)
  • 2018 (73)
  • 2017 (63)
  • 2016 (51)
  • 2015 (41)
  • 2014 (53)
  • 2013 (66)
  • 2012 (16)
  • 2011 (59)

Subject

  • Drug Trafficking (72)
  • Synthetic drugs (34)
  • Prescription Drugs (32)
  • Take Back Day (29)
  • Arrests/Convictions - Major (28)
  • Outreach/Drug Prevention (27)
  • Fake Pills (24)
  • Overdose (23)
  • Fentanyl Awareness (20)
  • Public and Media Affairs - also see Congressional Affairs (17)
  • Seizures (Drugs/Property) (16)
  • Guns/Weapons (14)
  • Major Law Enforcement Operation (14)
  • Diversion Division (13)
  • Pharmaceuticals/Pharmacists/Physicians (13)
  • Congressional Affairs (12)
  • One Pill Can Kill (12)
  • Press Conferences (12)
  • Prevention/Education - DEA websites GSAD, JTT etc (9)
  • Red Ribbon (9)
  • Money Laundering (8)
  • Narcoterrorism (7)
  • OCDETF/Task Force (7)
  • International/Foreign Operations (6)
  • Extraditions (4)
  • Fentanyl Free America (4)
  • Guilty Plea (4)
  • HIDTA (4)
  • Intergovernmental Affairs (4)
  • Counterfeit Pills (3)
  • Critical Incident (3)
  • Gangs (3)
  • Other (3)
  • Terrorism (3)
  • Campaigns (2)
  • Scam Calls (2)
  • Task Forces/Task Force Officers (2)
  • Dark Web- Internet Trafficking (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)

Drug Name

  • Fentanyl (74)
  • Methamphetamine (45)
  • Cocaine (35)
  • Heroin (17)
  • Marijuana (Cannabis) (8)
  • Synthetic Opioids (6)
  • Opioids (5)
  • Oxycodone (5)
  • Ketamine (2)
  • Marijuana Concentrates (2)
  • Benzodiazepines (1)
  • Ecstasy/MDMA (1)
  • GHB (1)
  • Psilocybin (1)

Field Division

  • New England (2385)
  • New York (1521)
  • Houston (907)
  • San Francisco (847)
  • Miami (840)
  • Seattle (812)
  • St. Louis (808)
  • Atlanta (777)
  • Chicago (629)
  • Washington, DC (617)
  • New Jersey (493)
  • New Orleans (481)
  • Detroit (361)
  • El Paso (350)
  • Dallas (315)
  • Phoenix (274)
  • San Diego (246)
  • Rocky Mountain (166)
  • Philadelphia (140)
  • Omaha (137)
  • Louisville (81)
  • Caribe (79)
  • Caribe (1)
  • Sede (414)
  • Los Angeles (300)
Clear All Results
709 Results - Showing 41 to 50
PRESS RELEASE

DEA Safely Disposes of 620,000 Pounds of Unused Medications on 28th National Prescription Drug Take Back Day

WASHINGTON – DEA and nearly 4,500 law enforcement agencies joined forces last month to dispose of more than 620,000 pounds of unneeded and expired medications in an effort to prevent drug misuse and abuse. The spring collection event marked DEA’s 28th National Prescription Drug Take Back Day. Since its inception...
PRESS RELEASE

DEA Seizes Record-Breaking 2.7 Million Fentanyl Pills

U.S. Attorney General Pam Bondi joined DEA Leadership, and the men and women of the DEA El Paso Field Division, on Tuesday, May 6, 2025 to announce the single largest seizure of fentanyl pills in DEA history. During an enforcement operation the last week of April, agents from the DEA...
PRESS RELEASE

Central Coast Woman Pleads Guilty to Misusing Doctors’ Credentials to Create Bogus Medical Documents for Immigration Applicants

LOS ANGELES – A San Luis Obispo County woman who operated a medical clinic pleaded guilty today to misusing physicians’ medical identities to create hundreds of fraudulent immigration documents to help immigrants obtain lawful status in the United States and for using a deceased doctor’s credentials to acquire and distributed...
PRESS RELEASE

DEA Recognizes 2025 National Fentanyl Awareness Day with Debut of Faces of Fentanyl Online Exhibit

WASHINGTON - DEA proudly joins community organizations, law enforcement, and public health partners in recognizing National Fentanyl Awareness Day on Tuesday, April 29, 2025. Fentanyl is the greatest drug threat facing the United States as drug-related overdoses remain the leading cause of death among Americans aged 18-44. [1] DEA will...
PRESS RELEASE

DEA’s National Take Back Day Returns April 26 to Help Prevent Prescription Drug Misuse

WASHINGTON, DC –The Drug Enforcement Administration, in coordination with more than 4,400 law enforcement partners across the country, will host the 28th National Prescription Drug Take Back Day Saturday, April 26, from 10 a.m. to 2 p.m., offering communities across the United States a safe, convenient, and anonymous way to...
PRESS RELEASE

Former Olympian Wanted for Running Transnational Drug Enterprise and Ordering Several Murders Added to FBI’s List of Ten Most Wanted Fugitives

LOS ANGELES – Former Olympic snowboarder and Canadian national, Ryan Wedding, 43, has been added to the FBI’s Ten Most Wanted Fugitives list, Akil Davis, the Assistant Director in Charge (ADIC) of the FBI’s Los Angeles Field Office, announced today during a press conference in Westwood. ADIC Davis was joined...
PRESS RELEASE

Armed Drug Cartel Member Sentenced to Over 20 Years in Prison for Trafficking Hundreds of Kilos of Cocaine and Methamphetamine

A Mexican national and armed member of the Cártel de Jalisco Nueva Generación (CJNG) was sentenced today in the District of Columbia to 20 years and 10 months in prison for his role in a conspiracy that distributed large quantities of cocaine and methamphetamine destined for the United States. “For...
PRESS RELEASE

DEA ‘One Pill Can Kill’ Campaign Championed by NFL Alumni Health

NEW ORLEANS – With so much attention ahead of Sunday’s big game, the U.S. Drug Enforcement Administration is once again teaming up with NFL Alumni Health to encourage football fans to join us in the fight to save lives. The need is critical and the game plan simple: understand the...
PRESS RELEASE

Career Special Agent Derek S. Maltz Appointed to Lead U.S. Drug Enforcement Administration

WASHINGTON – The Trump Administration has announced the appointment of Derek S. Maltz as Acting Administrator of the U.S. Drug Enforcement Administration. Maltz replaces Anne Milgram who departed the agency last week. Maltz is a passionate, dedicated, career special agent who served 28 years at DEA before retiring in 2014...
PRESS RELEASE

DEA Announces Three New Telemedicine Rules that Continue to Open Access to Telehealth Treatment while Protecting Patients

WASHINGTON – The U.S. Drug Enforcement Administration is announcing three new rules to make permanent some temporary telemedicine flexibilities established during the COVID-19 public health emergency while also establishing new patient protections. In developing these rules, DEA has focused on the patient to ensure telemedicine is accessible for medical care...

Paginación

  • Primera página «
  • Anterior
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Current page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster